2008 NSTI Nanotechnology Conference and Trade Show - Nanotech 2008 - 11th Annual
Technical Conferences
Merck Corporate Needs
NanoInk Symposium
Nano Electronics & Photonics
Nano Fabrication
MEMS & NEMS
Sensors & Systems
Micro & Nano Fluidics
MSM - Modeling Microsystems
WCM - Compact Modeling
Nanostructured Materials & Devices
Soft Nanotechnologies & Applications
Nanoparticles in Soft Materials - Colloidal Systems
Polymer Nanotechnology
Carbon Nano Structures & Devices
Nano Particles & Applications
Composites
Nanostructured Surfaces and Interfaces
Nanoscale Characterization
Energy Technologies & Applications
Nanotech in Health, Environment & Society
ICCN - Nanoscale Modeling
Nanoreliability
Bio Nano Materials & Tissues
Bio Sensors & Diagnostics
Biomarkers & Nanoparticles
Cancer Diagnostics, Imaging & Treatment
Drug Delivery & Therapeutics
Nano Medicine
Nanotech to Neurology
Phage Nanobiotechnology
Clean Technology 2008
Industrial Impact Workshop
Confirmed Speakers
Program Committee
Reviewers

Partnering Events:

TechConnect Summit
Clean Technology 2008
Alan Sachs

Alan Sachs

Vice President
RNA Therapeutics and Molecular Profiling
Merck Research Laboratories

Alan Sachs, vice president, RNA Therapeutics and Molecular Profiling, Merck Research Laboratories (MRL), assumed scientific leadership at Sirna Therapeutics and shared scientific leadership at Rosetta Inpharmatics, LLC in January 2007. Prior to that, he had responsibility for the scientific leadership at Rosetta Inpharmatics LLC beginning in July 2002 and responsibility for the Department of Molecular Profiling in 2006. Sachs joined Merck & Co., Inc. as director of Clinical Genomics for MRL in July 2001. He is one of the leading figures in the field of mRNA translation and regulation and has made landmark contributions, particularly to the understanding of the role of the poly(A) tail in translation and mRNA stability.

Speaking in the Merck Innovation Symposium: siRNA Delivery.


View Confimed Speakers

← Back to Conferences & Symposia